Cuttsy+Cuttsy is proud to have achieved a Platinum accreditation from Investors in People, placing them among the top 2% of ...

AI is shooting for the moon and the stars but the real benefits come from anchoring it to the human voice Research conducted ...

Approximately 121,000 people are diagnosed with primary advanced or recurrent endometrial cancer each year in Europe ...

Merck & Co – known as MSD outside the US and Canada – will be gaining exclusive global rights to Hansoh Pharma’s preclinical ...

At first glance, translating clinical outcome assessments (COAs) from their original language (most commonly English) to ...

The drug is already approved in the EU to treat ulcerative colitis, another form of inflammatory bowel disease ...

Since the Orphan Drug Act was passed in 1983, pharmaceutical companies have increasingly focused on developing treatments for ...

At its heart, it comes back to being able to convey empathy – ‘the ability to understand and imagine the feelings, ...

The results come two months after Merck shared positive results from the phase 3 KEYNOTE-689 trial of Keytruda as a ...

Who comes to mind when you think of people with lung cancer? Common stereotypes often depict older, male, life-long smokers, ...

The European Medicines Agency’s human medicines committee has recommended Galderma’s nemolizumab to treat atopic dermatitis ...

Technology’s ability to accelerate the pace of innovation while reducing the cost is changing the dynamic of the struggle ...